SCHEMBL7399387

SCHEMBL7399387

CC(N)CC1OCCc2ccccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.46
KMT2A Q03164 3/20 0.46
LMNA P02545 1/20 0.46
MAPT P10636 3/20 0.46
GAA P10253 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
TSHR P16473 1/20 0.45
RECQL P46063 1/20 0.45
TAAR1 Q96RJ0 2/20 0.44
XBP1 P17861 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43
MEN1 O00255 2/20 0.43
RAB9A P51151 1/20 0.43
BLM P54132 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HTR1A P08908 2/20 0.42
DRD2 P14416 2/20 0.42
DRD4 P21917 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13588569 0.87 MAPT (0.50) ALDH1A1KMT2ALMNAMAPTGAA
SCHEMBL28189241 0.80 ALDH1A1 (0.45) ALDH1A1KMT2ALMNAMAPTGAA
SCHEMBL13197463 0.78 ALDH1A1 (0.51) ALDH1A1KMT2ALMNAMAPTGAA
SCHEMBL4502485 0.78 HTR2A (0.53) ALDH1A1KMT2ALMNAMAPTGAA
SCHEMBL28189243 0.78 XBP1 (0.46) ALDH1A1KMT2ALMNAMAPTGAA
SCHEMBL14438274 0.77 ALDH1A1 (0.54) ALDH1A1KMT2ALMNAMAPTGAA
Hydrochloric Acid SCHEMBL27199265 0.77 TSHR (0.52) ALDH1A1KMT2ALMNAMAPTGAA
SCHEMBL28188595 0.77 ALDH1A1 (0.45) ALDH1A1KMT2ALMNAMAPTGAA
SCHEMBL10824468 0.76 ALDH1A1 (0.50) ALDH1A1KMT2ALMNAMAPTGAA
SCHEMBL28189242 0.76 ALDH1A1 (0.44) ALDH1A1KMT2ALMNAMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6133446-A Heterocyclic compounds for the treatment of CNS and cardiovascular disorders PHARMACIA & UPJOHN COMPANY (US) 2000-10-17 US disclosed
EP-0737189-B1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS UPJOHN CO (US) 1999-07-28 EP disclosed
US-5877317-A Heterocyclic compounds for the treatment of CNS and cardiovascular disorders PHARMACIA & UPJOHN COMPANY (US) 1999-03-02 US disclosed
WO-1995018118-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS THE UPJOHN COMPANY (US) 1995-07-06 WO disclosed